The NF-κB/HIF-1α signaling pathway maintains cancer stemness and high radioresistance in CD133-positive CSCs, whereas the inhibition of this HIF-1α involving pathway reverses the EMT and reduces the radioresistance in a model with laryngeal squamous carcinoma CNE-2 stem cells. The gene discussed is NFKB1; the disease is cancer.